Region
Featured experience
Atairos investment in the parent company of the Aston Villa Football Club
We are advising Atairos on the minority investment
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Haleon $3 billion secondary placing of ordinary shares
The private placement included 700,000,000 ordinary shares
$100 million investment by consortium in Airbus subsidiary AALTO
We are advising Airbus on the transaction
Asahi Kasei $1.1 billion offer to acquire Calliditas Therapeutics
We are advising Lazard as financial adviser to Calliditas on the transaction
CRH $1.5 billion guaranteed notes offering
The investment-grade notes are due 2029 and 2034
Banco Santander €1.5 billion cash tender offer for AT1 notes
We advised Banco Santander on its tender offer for contingent convertible perpetual notes
Deutsche Bank $1 billion notes offering
The fixed-rate senior debt funding notes are due 2029
NatWest Group $1 billion contingent convertible Additional Tier 1 notes
We advised NatWest Group on the SEC-registered offering
ADC Therapeutics $105 million follow-on offering
We advised ADC Therapeutics on its offering of shares and pre-funded warrants
GXO Logistics $1.1 billion notes offering
The investment-grade notes are due 2029 and 2034
Svitzer Group demerger and Copenhagen listing
We advised A.P. Moller – Maersk and Svitzer Group on the demerger and commencement of trading in shares of Svitzer Group
Puig €2.6 billion IPO
Puig’s Class B shares are listed on the Spanish Stock Exchanges